Clinical Trial Update: An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 induction study investigating the efficacy and safety of Duvakitug in moderately to severely active Crohn's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Duvakitug

Snippet

Sponsor: Sanofi | Conditions: Crohn's Disease | Phase 3 | Status: RECRUITING